Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SMMT
SMMT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SMMT News
Aehr Test Systems and MongoDB Show Active Options Trading
5d ago
NASDAQ.COM
Stifel Begins Coverage of Summit Therapeutics Inc with a Buy Rating and Sets Price Target at $45
Apr 08 2026
moomoo
Citi Identifies Stocks with Upside Amid U.S.-Iran Conflict
Mar 31 2026
CNBC
Summit Presents Updated Ivonescimab Data at ELCC 2026
Mar 27 2026
Newsfilter
Jefferies Downgrades Summit Therapeutics with Target Price Cut
Mar 26 2026
Yahoo Finance
Summit Therapeutics Faces FDA Review Risk for Ivonescimab
Mar 25 2026
Fool
Summit Therapeutics Faces FDA Approval Risk for Ivonescimab
Mar 25 2026
NASDAQ.COM
U.S. Markets Increased on Wednesday; Summit Therapeutics Led the Way
Mar 25 2026
Barron's
U.S. Stocks Fluctuate Amid Downward Revision of Economic Growth
Mar 13 2026
Benzinga
Summit Therapeutics Announces Upcoming Investor Conference Schedule
Feb 27 2026
Newsfilter
Summit Therapeutics to Participate in Upcoming Investor Conferences
Feb 26 2026
Businesswire
Summit Therapeutics Q4 2025 Earnings Call Highlights
Feb 24 2026
seekingalpha
Summit (SMMT) Q4 2025 Earnings Call Transcript
Feb 24 2026
NASDAQ.COM
Summit Therapeutics Reports Q4 Earnings Miss
Feb 23 2026
seekingalpha
US Supreme Court Strikes Down Trump's Tariff Regime
Feb 22 2026
Yahoo Finance
Summit Therapeutics Set to Announce Q4 Earnings on February 23
Feb 20 2026
seekingalpha
Show More News
